Premium
Integration of Nanoscale and Macroscale cues in Bone Regeneration
Author(s) -
Griffith Linda Gay,
Platt Manu,
Stockdale Linda,
Serdy James,
Alvarez Luis,
Lauffenburger Douglas,
Wells D.A.,
Muschler G.F.
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.69.2
Subject(s) - microbiology and biotechnology , stromal cell , regeneration (biology) , epidermal growth factor , growth factor , scaffold , mesenchymal stem cell , bone marrow , signal transduction , chemistry , biology , immunology , cancer research , receptor , medicine , biomedical engineering , biochemistry
Marrow stromal cells (MSC) can act as a pluripotent source of reparative cells during injury. Many envisioned applications of MSC, such as treating large defects in bone, involve in vivo implantation of MSC attached to a scaffold, a process that creates an acute inflammatory environment that may be hostile to MSC survival and proliferation ‐ especially in large defects. We address ways of integrating nanoscale control of growth factor presentation with macroscale design of scaffold architecture with an eye toward influencing multiple biological processes, including growth, proliferation, migration, and differentiation of cells that contribute to bone formation. We have focused especially on the role of epidermal growth factor (EGF) receptor signalling. For some cell types, soluble EGF acts as a survival signal in the face of pro‐death stimuli, but MSC appear refractory toward survival when challenged with pro‐death stimuli in the presence of soluble EGF. In contrast, when EGF is covalently tethered to the scaffold, it can activate the EGFR signaling pathways and strongly promotes spreading and survival of MSC. Substrate‐tethered EGF also influences proliferation, colony formation, and differentiation of human MSC, hence holds potential for enhancing bone regeneration.